DiacetololAlternative Names: EU 4891; M&B 16942A
Latest Information Update: 02 Sep 2002
At a glance
- Originator May & Baker
- Class Antihypertensives; Propanolamines; Small molecules
- Mechanism of Action Beta-adrenergic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 21 Feb 2002 Discontinued-unspecified phase for Hypertension